Story at-a-glance Glioblastoma stands as one of the most aggressive brain cancers, with median survival ranging from just 12 to 15 months after diagnosis.1 This disease is characterized by persistent headaches, seizures, memory loss, confusion, and progressive neurological decline. Once it takes hold, it disrupts normal brain function and often resists […]
The post What Niacinamide Studies May Reveal About Cancer as a Metabolic Disease appeared first on Activist Post.
